PT  - JOURNAL ARTICLE
ED  - ,
TI  - Kanamycin
AID  - 10.1136/dtb.s1-2.2.6
DP  - 1963 Jan 25
TA  - The British Edition of the Medical Letter on Drugs and
				Therapeutics
PG  - 6--8
VI  - s1-2
IP  - 2
4099  - http://dtb.bmj.com/content/s1-2/2/6.short
4100  - http://dtb.bmj.com/content/s1-2/2/6.full
AB  - Kanamycin sulphate (Kannasyn - Bayer) was introduced in Britain in 1959 mainly for use against resistant staphylococci. More recently the manufacturers have re-assessed the drug, and they now advocate it only for infections caused by Gram-negative organisms.